Role of Biomaterials in treatment of Alzheimer’s disease: A literature review
Currently, five medications have been approved by the FDA to treat Alzheimer's disease (AD); Donepezil, which is used at all stages of AD, galantamine, and rivastigmine for mild to moderate stages, and Memantine and a combination of Memantine and donepezil for moderate to severe stages. The abi...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Iran University of Medical Sciences
2022-12-01
|
| Series: | Neurology Letters |
| Subjects: | |
| Online Access: | https://www.neurologyletters.com/article_164012_c8a958a71f54b569e1ef0b18f51f5309.pdf |